共 50 条
- [21] Rezvilutamide for metastatic hormone-sensitive prostate cancer LANCET ONCOLOGY, 2022, 23 (11): : E491 - E491
- [24] Targeting Metastatic Hormone Sensitive Prostate Cancer: Chemohormonal Therapy and New Combinatorial Approaches JOURNAL OF UROLOGY, 2019, 201 (05): : 876 - 885
- [25] Docetaxel for hormone-sensitive metastatic prostate cancer LANCET ONCOLOGY, 2015, 16 (09): : E432 - E432